RochePDSmeeting-evaluation

First Name *

Last Name *

1. How was your overall experience with the meeting? (Please rate on a scale of ‘10=Excellent' to ‘1= Very poor’) *

2. Please rate the degree to which you agree or disagree with each of the following statements related to the organization of the meeting.*

a) The date, time and duration of the meeting are convenient *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeStrongly Agree	AgreeAgree	NeutralNeutral	DisagreeDisagree	Strongly DisagreeStrongly Disagree

b) The use of online platform is appropriate *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

c) There was sufficient time for discussions and questions *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

d) Overall, I am satisfied with this meeting *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

3. Please rate the degree to which you agree or disagree with each of the following statements related to the content of the meeting.*

a) The meeting provided an in-depth information on the science of PDS including the surgical procedures involved *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

b) Cross-country experience sharing on using PDS, in both clinical trial and real-world settings, is valuable *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

c) After this meeting, I have a clearer understanding on how to select patients for treatment with ranibizumab PDS *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

d) After this meeting, I am more confident in offering ranibizumab PDS to suitable patients in the real-world setting *

Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Strongly AgreeItem #1 Strongly Agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly DisagreeItem #1 Strongly Disagree

4. What did you like most about the meeting?

5. Do you have any further comments regarding this meeting?